RECITALS:Agreement • August 14th, 1998 • Cytogen Corp • In vitro & in vivo diagnostic substances • New York
EXHIBIT 10.2 Agreement to Amend the Agreement to Terminate License, Supply and Marketing Agreement ("Termination Agreement") and Letter Agreement Respecting Reimbursement of Expenses ("Letter Agreement"). This Agreement to Amend the Termination...Letter Agreement • August 14th, 1998 • Cytogen Corp • In vitro & in vivo diagnostic substances
EXHIBIT 10.1 [DuPont Merck Letterhead] June 3, 1998 John E. Bagalay, Ph.D. President & CEO Cytogen Corporation 600 College Road East Princeton, NJ 08540-5308 Dear John: This Letter Agreement ("Agreement") is intended to confirm our mutual agreement...Letter Agreement • August 14th, 1998 • Cytogen Corp • In vitro & in vivo diagnostic substances • Delaware
